Fidelity Advisor® Biotechnology Fund

Scorecard
4 / 5 Stars
Lipper
4 4 4 4 4
Zacks Investment Research
3 (Hold)
Standard & Poor's
5 / 5 Stars
TheStreet.com
A (Buy)

Fund Fees

Updated 09.28.2013

Maximum Sales Fees %
Initial
Deferred 1.0

Updated 09.28.2013

Maximum Fees %
Administrative
Management 0.55
Redemption 0.75

Updated 09.28.2013

Actual Fees %
12b-1 1.0
Management 0.55
Net Expense Ratio: Annual Report 1.87
Net Expense Ratio: Prospectus 1.88

Updated 03.05.2014

Total Cost Projections
3-Year $591.00
5-Year $1,016.00
10-Year $2,201.00

Purchase Information

Updated 09.28.2013

Minimum Investments
Initial $2,500.00
Additional
Initial IRA $500.00
Additional IRA
Initial AIP $2,500.00
Additional AIP $100.00